von Hippel-Lindau Disease Clinic
John Heiss, M.D., Clinic Director
Patients with von Hippel-Lindau disease (VHL) and central nervous system tumors (hemangioblastomas and endolymphatic sac tumors) are evaluated, treated and followed in the clinic. Information from clinical, imaging, laboratory and pathologic tissue from patients with VHL is used to develop deeper insights into VHL tumor biology, therapeutic targets, optimal timing of treatment and improved therapies.
For more information contact: Gretchen Scott, R.N. at email@example.com.